Vericel (VCEL) Enterprise Value (2010 - 2026)
Vericel's (VCEL) quarterly Enterprise Value came in at -$145.3 million in Q1 2026, down 82.35% year-on-year from -$823.3 million in Q1 2025, and down 5.7% quarter-over-quarter from -$137.5 million in Q4 2025.
Vericel (VCEL) Enterprise Value (2010 - 2026) Analysis & Trends
Vericel has disclosed Enterprise Value across 15 years of filings, most recently posting -$145.3 million for Q1 2026.
- Enterprise Value for Q1 2026 came in at -$145.3 million, down 82.35% year-over-year; the trailing twelve-month figure through Mar 2026 was -$145.3 million (down 82.35% YoY), and the FY2025 annual result was -$137.5 million, down 18.32% from the prior year.
- Enterprise Value came in at -$145.3 million for Q1 2026 at Vericel, down from -$137.5 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$51.1 million in Q4 2022 to a low of -$145.3 million in Q1 2026.
- The 5-year median for Enterprise Value is -$100.7 million (2022), against an average of -$101.7 million.
- Across the five-year window, Enterprise Value jumped 50.61% in 2022 and plunged 92.44% in 2025, its largest moves.
- Vericel's Enterprise Value stood at -$51.1 million in 2022, then plunged by 70.1% to -$86.9 million in 2023, then slumped by 33.78% to -$116.2 million in 2024, then dropped by 18.32% to -$137.5 million in 2025, then retreated by 5.7% to -$145.3 million in 2026.
- The last three Enterprise Value figures came in at -$145.3 million (Q1 2026), -$137.5 million (Q4 2025), and -$135.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -584.73 Mn |
| 10 | Vericel | 2.04 Bn | 1.90 Bn | 49.27 Mn | -145.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -145.34 Mn |
| Dec 31, 2025 | -137.50 Mn |
| Sep 30, 2025 | -135.38 Mn |
| Jun 30, 2025 | -80.53 Mn |
| Mar 31, 2025 | -79.71 Mn |
| Dec 31, 2024 | -116.21 Mn |
| Sep 30, 2024 | -70.35 Mn |
| Jun 30, 2024 | -102.51 Mn |
| Mar 31, 2024 | -110.65 Mn |
| Dec 31, 2023 | -86.87 Mn |
| Sep 30, 2023 | -83.56 Mn |
| Jun 30, 2023 | -97.83 Mn |
| Mar 31, 2023 | -119.28 Mn |
| Dec 31, 2022 | -51.07 Mn |
| Sep 30, 2022 | -110.94 Mn |
| Jun 30, 2022 | -100.69 Mn |
| Mar 31, 2022 | -100.55 Mn |
| Dec 31, 2021 | -103.40 Mn |
| Sep 30, 2021 | -98.29 Mn |
| Jun 30, 2021 | -90.98 Mn |